Latest Lymphocytic Leukemia Stories
SUNNYVALE, Calif., May 1, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
SEATTLE, April 21, 2015 /PRNewswire/ -- Seattle Children's announced today that 20 of 22 patients treated thus far in a clinical trial using genetically reprogrammed T cells to treat relapsed
Oral Presentation at the American Association of Cancer Research Annual Meeting PHILADELPHIA, April 20, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
SUNNYVALE, Calif., April 1, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
WHITE PLAINS, N.Y., March 30, 2015 /PRNewswire-USNewswire/ -- A promising University of Michigan research project focused on developing new treatments for patients with a rare and lethal subtype
Highly sensitive genomic analysis of acute lymphoblastic leukemia cells reveals for the first time how the malignant cells evolve to cause relapse MEMPHIS, Tenn., March 19, 2015 /PRNewswire-USNewswire/
Pre-clinical data to be presented in solid tumor and blood cancer models SUNNYVALE, Calif., March 19, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
Independent Data Monitoring Committee determines HELIOS study meets its primary endpoint of progression-free survival in patients with previously treated chronic lymphocytic leukemia/small lymphocytic
SUNNYVALE, Calif., March 16, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
- Emitting flashes of light; glittering.